3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Ovarian Neoplasms
5
Breast Neoplasms
3
Prostatic Neoplasms
2
Fallopian Tube Neoplasms
2
Uterine Neoplasms
1
Sarcoma
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
MMR-D/MSI-H Colorectal Cancers
1
Lymphoma
1
Leiomyosarcoma
1
Glioblastoma
1
Endometrial Neoplasms
1
Cystadenocarcinoma, Serous
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Interventions
niraparib
1
Prednisone
1
Docetaxel
1
Androgen Antagonists
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
niraparib
×
Clear all
NCT06392841
2026-04-08
HARMONY
Hoosier Cancer Research Network
Phase 2
Withdrawn